Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aegis Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011813
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aegis Therapeutics LLC (Aegis Therapeutics) is a biotechnology company that research and develops drug delivery and drug formulation technologies. The company commercializes new drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and biopharmaceutical companies. It provides a drug delivery technology that allows the non invasive delivery of a broad range of protein, peptide, nucleotide, non peptide and other small and large molecule drugs. Aegis Therapeutics also provides protein stabilization technology, which creates homogeneous, stable, aqueous or lyophilized dosage forms for peptide or protein therapeutics. Aegis Therapeutics is headquartered in San Diego, California, the US.

Aegis Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Aegis Therapeutics Enters into Co-Development Agreement with Albany Medical College 10
Licensing Agreements 12
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 14
Biodel Enters Into Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 15
Aegis Therapeutics LLC – Key Competitors 16
Aegis Therapeutics LLC – Key Employees 17
Aegis Therapeutics LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aegis Therapeutics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aegis Therapeutics Enters into Co-Development Agreement with Albany Medical College 10
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 14
Biodel Enters Into Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 15
Aegis Therapeutics LLC, Key Competitors 16
Aegis Therapeutics LLC, Key Employees 17

★海外企業調査レポート[Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Fertilizers Limited (NFL):企業財務及び戦略的SWOT分析
    Summary National Fertilizers Limited (NFL) is a chemical company that develops urea and bio-fertilizers. The company offers products such as kisan urea, neem coated urea, bio-fertilizers, industrial products and traded products. It provides bio-fertilizer such as nitrogenbio-fertilizer and phosphoro …
  • Infosys Limited:企業の戦略・SWOT・財務分析
    SummaryInfosys Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • American Financial Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Financial Group, Inc. …
  • YASKAWA INFORMATION SYSTEMS Corporation (2354):企業財務及び戦略的SWOT分析
    Summary YASKAWA INFORMATION SYSTEMS Corporation (YASKAWA), a subsidiary of Yaskawa Electric Corporation is an information technology company that offers system development, appliance, hardware and software products. The company's products comprise ACE-eye, BeauStudio, Control Web 2000, EneSight for …
  • Deutsche Lufthansa AG:企業のM&A・事業提携・投資動向
    Deutsche Lufthansa AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Lufthansa AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Energy Transfer Partners, L.P. (ETP):企業のM&A・提携動向(石油・ガス分野)
    Summary Energy Transfer Partners, L.P. (ETP) is a master limited partnership. It owns and operates diversified portfolio of energy assets in the US. The partnership carries out the gathering, processing, storage, intra- and interstate transportation of natural gas and natural gas liquids. ETP also c …
  • Altana AG:企業の戦略的SWOT分析
    Altana AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Hertz Global Holdings, Inc.:企業の戦略・SWOT・財務分析
    SummaryHertz Global Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Semiconductor Manufacturing International Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Semiconductor Manufacturing Int …
  • China Bio Cassava Holdings Limited (8129):企業概要、財務及び戦略的SWOT分析
    Summary China Bio Cassava Holdings Limited (CBC) is an investment holding company. The company develops, sells and distributes, and licenses the computer software and embedded systems, as well as develops the biotech and renewable energy. Its products and services include the Matrix mapping system, …
  • Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • Immuron Limited (IMC)(製薬・医療分野):企業M&A動向
    Summary Immuron Limited (Immuron) is a biopharmaceutical company. The company conducts research and develops polyclonal antibody products for humans. Its products include Travelan, IMM-272, IMM 124-E, IMM 529, IMM 363, and IMM 160. The company’s IMM 124-E is a product for the treatment of non-alcoho …
  • Infinitt Healthcare Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Infinitt Healthcare Co., Ltd. M …
  • Bicycle Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bicycle Therapeutics Ltd (Bicycle Therapeutics) is a biotechnology company that develops bicyclic peptides Medicines for the treatment of cancers and other debilitating diseases. The company's proprietary bicyclic peptide technology enables systematic cyclisation of peptides and helps to ide …
  • Fujifilm SonoSite Inc-医療機器分野:企業M&A・提携分析
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • Zeltia, S.A. (ZEL):企業概要、財務及び戦略的SWOT分析
    Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops new oncology drugs of marine origin; provides molecular diagnostic solutions based on DNA an …
  • Innovative Biosensors, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Innovative Biosensors, Inc. (IBI) is a medical device company. The company develops, manufactures and markets rapid pathogen detection and diagnostic systems comprised of biosensors. Its BioFlash device is a rapid diagnostic system for the ultra-sensitive detection of pathogens based on the …
  • Pfizer Inc. (PFE):企業の財務及び戦略的SWOT分析
    Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Capnia Inc (CAPN):企業財務及び戦略的SWOT分析
    Summary Capnia Inc (Capnia) is a medical equipment company that designs, develops and commercializes novel therapeutic and diagnostic products. The company’s products include serenz and cosense. Its serenz is a hand-held device, which is used to obtain relief from the symptoms of allergies. Capnia's …
  • SAS Group:企業の戦略・SWOT・財務分析
    SummarySAS Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - De …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆